Cigna Corporation ($CI) Stock Forecast: Up 1.8% Today

What is Cigna Corporation?

CI Stock CI is a stock in the healthcare sector, potentially related to health insurance or healthcare services. Today, the market movement for CI was bullish.

Why is Cigna Corporation going up?

CI stock is up 1.8% on Jan 2, 2026 16:41

• The bullish movement in CI stock today could be attributed to positive news surrounding a new deal between Cigna and Tenet Healthcare Corp in Florida. This deal ensures continued in-network access for policyholders, potentially avoiding higher out-of-network costs and boosting investor confidence in CI.
• The inclusion of healthcare stocks, like CI, in a list of top 10 stock picks by a major financial institution, emphasizing diverse catalysts such as healthcare legislation, may have also contributed to the positive market sentiment in the healthcare sector.
• Despite certain pressures on another healthcare stock, CI's bullish movement today might suggest that investors perceive it to be better positioned to address challenges related to Medicare Advantage and rising medical costs effectively.
• The favorable outlook for healthcare stocks, supported by recommendations and market performance, likely influenced the bullish movement observed in CI today.

CI Price Chart

CI Technical Analysis

CI News

Bank of America unveils top 10 stock picks for Q1 2026 with diverse catalysts

Bank of America has released its top 10 stock recommendations for Q1 2026, comprising nine Buy ratings and one Underperform across various industries. While AI remains a significant theme, the firm highlights other diverse catalysts for these picks, including healthcare legislation, commercial production rates, and tax refunds. InvestingPro data also shows strong performance for Dollar General, one of the recommended Buy stocks, with an impressive 80% return over the past year.

https://www.investing.com/news/analyst-ratings/bank-of-america-unveils-top-10-stock-picks-for-q1-2026-with-diverse-catalysts-93CH-4427835

Humana’s Stock Under Pressure: Can The Health Insurance Giant Reclaim Its Former Momentum?

Humana's stock has been trending downwards, reflecting investor concerns about Medicare Advantage and rising medical costs, placing it at a critical juncture. Despite mixed analyst sentiment and a soft near-term outlook, the company's long-term prospects are tied to healthcare demographics and its ability to manage costs effectively. The market is waiting for clearer evidence that cost pressures are subsiding before the stock can reclaim its former momentum.

https://www.ad-hoc-news.de/boerse/ueberblick/humana-s-stock-under-pressure-can-the-health-insurance-giant-reclaim/68450392

Cigna and Tenet's new deal keeps 1.3 million Floridians in-network for health care services

Cigna and Tenet Healthcare Corp. have reached a new agreement, ensuring that 1.3 million Cigna policyholders in Florida, including 13,000 in Palm Beach County, will maintain in-network access to Tenet's hospitals and medical services. This deal prevents patients from facing higher out-of-network costs. The previous negotiations were contentious, particularly regarding Cigna's use of algorithms and AI in patient care decisions.

https://www.wpbf.com/article/cigna-tenet-reach-deal-avoiding-out-of-network-costs-for-patients/69894874

Abbott Laboratories (ABT): Buy, Sell, or Hold Post Q3 Earnings?

Abbott Laboratories (ABT) shares have declined by 7.9% over the past six months, prompting investor reevaluation. The company benefits from economies of scale and robust free cash flow margins, averaging 16.8% over five years. However, its long-term revenue growth has been a mediocre 6.4% compounded annually over the same period.

https://finviz.com/news/265732/abbott-laboratories-abt-buy-sell-or-hold-post-q3-earnings

Abbott Laboratories (ABT): Buy, Sell, or Hold Post Q3 Earnings?

Abbott Laboratories (ABT) shares have underperformed the S&P 500 significantly over the past six months, prompting investor questions about its future. Despite this, the company benefits from strong economies of scale and excellent free cash flow margins, offering significant advantages in the healthcare industry. While its long-term revenue growth has been modest, the company's strengths outweigh its weaknesses, making it a potential buy, especially given its current valuation.

https://au.finance.yahoo.com/news/abbott-laboratories-abt-buy-sell-040446960.html

Trending Today

Pepe ($PEPE) Crypto Forecast: Up 8.6% Today

dogwifhat ($WIF) Crypto Forecast: Up 11.7% Today

Bonk ($BONK) Crypto Forecast: Up 6.6% Today

Cigna Corporation Price History

30.00.2025 - CI Stock was down 8.9%

• Cigna's stock declined today following a Q4 earnings miss, with adjusted earnings per share falling below analyst forecasts.
• Although the reported revenue exceeded expectations, the lower-than-expected earnings per share was a disappointment for investors.
• By acknowledging the current challenges and outlining plans for improvement, Cigna demonstrates proactive efforts to address issues and potentially restore investor trust in the future.

02.00.2026 - CI Stock was up 1.8%

• The bullish movement in CI stock today could be attributed to positive news surrounding a new deal between Cigna and Tenet Healthcare Corp in Florida. This deal ensures continued in-network access for policyholders, potentially avoiding higher out-of-network costs and boosting investor confidence in CI.
• The inclusion of healthcare stocks, like CI, in a list of top 10 stock picks by a major financial institution, emphasizing diverse catalysts such as healthcare legislation, may have also contributed to the positive market sentiment in the healthcare sector.
• Despite certain pressures on another healthcare stock, CI's bullish movement today might suggest that investors perceive it to be better positioned to address challenges related to Medicare Advantage and rising medical costs effectively.
• The favorable outlook for healthcare stocks, supported by recommendations and market performance, likely influenced the bullish movement observed in CI today.

31.09.2024 - CI Stock was up 3.1%

• CI's strong bullish movement today could be attributed to the anticipation of positive Q3 earnings, driven by the performance of its Evernorth unit.
• The expected benefit from the strength in the specialty pharmacy business might have contributed to investor optimism, leading to the bullish market movement.
• Despite concerns about elevated medical costs due to higher utilization trends, the market seems to be focusing more on the potential growth prospects for CI in the upcoming earnings report.

02.04.2025 - CI Stock was down 2.1%

• The strong Q1 earnings and increased outlook suggest that Cigna's growth platforms are performing well.
• The bearish movement in the stock could be attributed to profit-taking by investors following a period of strong performance.
• Market sentiment may have been influenced by external factors or concerns about future growth potential despite the positive earnings.
• Some investors may have anticipated even higher earnings or guidance, prompting a sell-off in the stock.

31.00.2025 - CI Stock was up 6.0%

• Despite reporting lower-than-expected earnings for Q4, Cigna's stock experienced a bullish movement.
• The positive market reaction may be linked to the company's proactive approach to addressing the earnings miss and implementing corrective measures.
• Investors seem to be optimistic about the revenue beat, indicating growth potential for Cigna in the future.
• The uptick in the stock price could be influenced by general market sentiment or external factors benefiting the healthcare sector.

05.01.2024 - CI Stock was up 5.1%

• Cantor Fitzgerald raised Cigna to overweight and increased its target price, indicating positive sentiment towards the stock.
• Cigna reported strong Q4 results, beating profit and sales estimates, and provided strong guidance. This likely contributed to the bullish movement.
• The company also raised its dividend and experienced membership growth, further boosting investor confidence.
• The overall positive market sentiment, driven by expectations of a Fed pivot and strong economic growth, may have also played a role in the bullish movement of Cigna stock.

11.11.2023 - CI Stock was up 12.2%

• Cigna's stock surged after raising its buyback by $10 billion and stepping away from a possible merger with Humana.
• The decision to withdraw from the major deal with Humana was due to shareholder resistance.
• The increased share buyback plan by Cigna indicates confidence in its own stock and potential for future growth.
• The news of Cigna abandoning its pursuit of Humana may have reassured investors and contributed to the bullish movement of the stock.

03.01.2024 - CI Stock was up 5.1%

• Cigna beat profit and sales estimates, posted strong guidance, and raised its dividend, which contributed to the bullish movement.
• The company's membership growth and expected revenue growth also positively impacted the stock.
• The announcement of stellar fourth-quarter results further fueled the bullish sentiment.
• Overall, Cigna's strong financial performance, positive outlook, and dividend increase drove the bullish market movement for the stock.

11.11.2023 - CI Stock was up 13.6%

• Cigna's stock rose sharply in pre-market trading.
• Cigna announced that it has withdrawn from its proposed merger with Humana Inc.
• Cigna's decision to end the merger talks and focus on other opportunities led to a positive market reaction.
• Additionally, Cigna approved a new $10 billion buyback, which further boosted investor confidence and contributed to the bullish movement.

11.11.2023 - CI Stock was up 7.2%

• Cigna has terminated its merger plans with Humana following shareholder resistance.
• Cigna has increased its share buyback plan by $10 billion and abandoned its bid to buy rival Humana.
• Cigna is planning a "significant" increase in its stock buyback and will focus on acquiring smaller companies in the same industry.
• Cigna's CEO, David Cordani, believes that the company's shares are significantly undervalued.
• Overall, Cigna's bullish movement can be attributed to the company's decision to call off the merger with Humana and focus on stock buybacks, which indicates confidence in the company's future prospects. The increased buyback plan and potential acquisitions in the industry also contribute to the positive market sentiment.

11.11.2023 - CI Stock was up 13.3%

• Cigna's stock had a bullish movement today, possibly influenced by the news of Cigna dropping its bid to buy health insurance rival Humana. This decision may have been seen as a positive move for Cigna, allowing the company to focus on other growth opportunities.
• The article also mentions an LBO bid for Macy's, which could have contributed to the overall bullish sentiment in the market, as investors may have viewed this as a positive development for the retail sector.
• Additionally, the article discusses upcoming central bank meetings and potential rate cuts in 2024, which could have generated optimism among investors and contributed to the bullish market movement.
• It's worth noting that the article mentions Sea Ltd ADRs falling, but since we are focusing on Cigna, this news is not directly related to the bullish movement of CI's stock.

03.09.2025 - CI Stock was up 4.7%

• The uptick in short interest may suggest a pessimistic outlook on Cigna Group among investors.
• Despite the growth in short interest, there is a sense of optimism regarding the company's future growth prospects and profitability.
• The positive movement in CI's stock price today could be connected to strong earnings results or strategic business advancements that have inspired confidence in investors.
• The market may be reevaluating the company's worth and potential for growth, leading to heightened buying activity and an increase in the stock price.